athenahealth, Inc. (NASDAQ:ATHN) Price Target Raised to $184.00

athenahealth, Inc. (NASDAQ:ATHN) had its price target raised by Oppenheimer Holdings, Inc. from $154.00 to $184.00 in a research report issued on Friday, July 21st. The firm currently has an “outperform” rating on the health services provider’s stock. Oppenheimer Holdings, Inc.’s target price suggests a potential upside of 30.18% from the company’s previous close.

Several other research firms have also commented on ATHN. BidaskClub upgraded shares of athenahealth from a “hold” rating to a “buy” rating in a research report on Saturday, June 24th. Jefferies Group LLC reiterated a “hold” rating and issued a $135.00 price objective on shares of athenahealth in a research report on Monday, June 26th. William Blair restated a “market perform” rating on shares of athenahealth in a report on Friday, July 21st. Piper Jaffray Companies restated an “overweight” rating and issued a $171.00 target price on shares of athenahealth in a report on Friday, July 21st. They noted that the move was a valuation call. Finally, J P Morgan Chase & Co set a $136.00 target price on shares of athenahealth and gave the company a “hold” rating in a report on Wednesday, July 19th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and thirteen have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $148.64.

Shares of athenahealth (NASDAQ ATHN) traded up 0.30% during midday trading on Friday, hitting $141.34. 393,900 shares of the company traded hands. The company has a 50-day moving average price of $142.46 and a 200-day moving average price of $126.16. The stock has a market capitalization of $5.64 billion, a P/E ratio of 179.37 and a beta of 1.77. athenahealth has a 52 week low of $90.11 and a 52 week high of $158.66.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, topping the consensus estimate of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The business had revenue of $301.10 million for the quarter, compared to analyst estimates of $298.68 million. During the same period in the previous year, the firm earned $0.34 EPS. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. Analysts anticipate that athenahealth will post $1.91 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was first posted by BNB Daily and is the property of of BNB Daily. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/athenahealth-inc-nasdaqathn-price-target-raised-to-184-00-updated-updated-updated.html.

In other news, CEO Jonathan Bush sold 4,000 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $140.52, for a total transaction of $562,080.00. Following the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $44,939,279.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Karl Stubelis sold 3,952 shares of the firm’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $138.98, for a total value of $549,248.96. Following the transaction, the chief financial officer now directly owns 21,810 shares in the company, valued at $3,031,153.80. The disclosure for this sale can be found here. Insiders sold 14,874 shares of company stock worth $2,102,697 over the last ninety days. 3.20% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Toronto Dominion Bank acquired a new position in shares of athenahealth during the second quarter worth approximately $16,863,000. 1st Global Advisors Inc. acquired a new position in shares of athenahealth during the second quarter worth approximately $243,000. Verition Fund Management LLC acquired a new position in shares of athenahealth during the second quarter worth approximately $272,000. Raymond James Financial Services Advisors Inc. purchased a new position in athenahealth during the second quarter worth about $548,000. Finally, The Manufacturers Life Insurance Company raised its position in athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after buying an additional 84 shares during the last quarter.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply